Morepen Laboratories
CEP Certificates (EDQM COS List)

Morepen Laboratories

CEP Database

Certificates of Suitability to the European Pharmacopoeia (CEP), issued by the EDQM.

Chemical India
  • Total Records 14
  • Latest End Date -
  • Data Source EDQM
  • Last Updated 2026-01-26
Company Overview

Company

Morepen Laboratories

Country

India

Social Profiles

LinkedIn
Company Snapshot

Morepen Laboratories

Morepen Laboratories Ltd., 2nd Floor, Tower C, DLF Cyber Park, Udyog Vihar, Sector -20, Gurgaon - 122016

India

morepen.com/ corporate@morepen.com View on Map
CEP Records Timeline (14 records)
2026
26 Jan
Chemical Valid

Product

Rupatadine fumarate

Substance

MOREPEN LABORATORIES LIMITED Baddi IN

Certificate No.

CEP 2025-532 - Rev 00

Substance No.

2888

Issue Date

2026-01-26

End Date

-

Country

India

Identifiers

Certificate No.: CEP 2025-532 - Rev 00
Substance No.: 2888

2025
22 Jul
Chemical Valid

Product

Desloratadine, Milled, micronised

Substance

MOREPEN LABORATORIES LIMITED Baddi IN

Certificate No.

CEP 2014-302 - Rev 01

Substance No.

2570

Issue Date

2025-07-22

End Date

-

Country

India

Identifiers

Certificate No.: CEP 2014-302 - Rev 01
Substance No.: 2570

2025
23 May
Chemical Valid

Product

Fexofenadine hydrochloride

Substance

MOREPEN LABORATORIES LIMITED Baddi IN

Certificate No.

CEP 2015-256 - Rev 01

Substance No.

2280

Issue Date

2025-05-23

End Date

-

Country

India

Identifiers

Certificate No.: CEP 2015-256 - Rev 01
Substance No.: 2280

2025
13 May
Chemical Valid

Product

Sitagliptin phosphate monohydrate

Substance

MOREPEN LABORATORIES LIMITED Baddi IN

Certificate No.

CEP 2019-040 - Rev 01

Substance No.

2778

Issue Date

2025-05-13

End Date

-

Country

India

Identifiers

Certificate No.: CEP 2019-040 - Rev 01
Substance No.: 2778

2025
05 Mar
Chemical Valid

Product

Rosuvastatin calcium, Process 4

Substance

MOREPEN LABORATORIES LIMITED Baddi IN

Certificate No.

CEP 2025-007 - Rev 00

Substance No.

2631

Issue Date

2025-03-05

End Date

-

Country

India

Identifiers

Certificate No.: CEP 2025-007 - Rev 00
Substance No.: 2631

2024
16 Dec
Chemical Valid

Product

Montelukast sodium, Milled and micronised

Substance

MOREPEN LABORATORIES LIMITED Baddi IN

Certificate No.

CEP 2012-003 - Rev 02

Substance No.

2583

Issue Date

2024-12-16

End Date

-

Country

India

Identifiers

Certificate No.: CEP 2012-003 - Rev 02
Substance No.: 2583

2024
13 Nov
Chemical Valid

Product

Rosuvastatin calcium, Process 3

Substance

MOREPEN LABORATORIES LIMITED Baddi IN

Certificate No.

CEP 2022-385 - Rev 00

Substance No.

2631

Issue Date

2024-11-13

End Date

-

Country

India

Identifiers

Certificate No.: CEP 2022-385 - Rev 00
Substance No.: 2631

2024
23 Sep
Chemical Valid

Product

Olmesartan medoxomil

Substance

MOREPEN LABORATORIES LIMITED Baddi IN

Certificate No.

CEP 2021-485 - Rev 00

Substance No.

2600

Issue Date

2024-09-23

End Date

-

Country

India

Identifiers

Certificate No.: CEP 2021-485 - Rev 00
Substance No.: 2600

2024
16 Sep
Chemical Valid

Product

Loratadine, Milled, micronised

Substance

MOREPEN LABORATORIES LIMITED Baddi IN

Certificate No.

CEP 2007-348 - Rev 05

Substance No.

2124

Issue Date

2024-09-16

End Date

-

Country

India

Identifiers

Certificate No.: CEP 2007-348 - Rev 05
Substance No.: 2124

2024
19 Aug
Chemical Valid

Product

Sitagliptin phosphate monohydrate, Process 2

Substance

MOREPEN LABORATORIES LIMITED Baddi IN

Certificate No.

CEP 2024-133 - Rev 00

Substance No.

2778

Issue Date

2024-08-19

End Date

-

Country

India

Identifiers

Certificate No.: CEP 2024-133 - Rev 00
Substance No.: 2778

2024
08 Jul
Chemical Valid

Product

Atorvastatin calcium, Micronised

Substance

MOREPEN LABORATORIES LIMITED Baddi IN

Certificate No.

CEP 2012-179 - Rev 05

Substance No.

2191

Issue Date

2024-07-08

End Date

-

Country

India

Identifiers

Certificate No.: CEP 2012-179 - Rev 05
Substance No.: 2191

2023
16 Jan
Chemical Valid

Product

Rivaroxaban

Substance

MOREPEN LABORATORIES LIMITED Baddi IN

Certificate No.

R0-CEP 2021-369 - Rev 00

Substance No.

2932

Issue Date

2023-01-16

End Date

-

Country

India

Identifiers

Certificate No.: R0-CEP 2021-369 - Rev 00
Substance No.: 2932

2023
22 Jun
Chemical Valid

Product

Rosuvastatin calcium, Process 2

Substance

MOREPEN LABORATORIES LIMITED New Delhi IN

Certificate No.

R1-CEP 2017-153 - Rev 00

Substance No.

2631

Issue Date

2023-06-22

End Date

-

Country

India

Identifiers

Certificate No.: R1-CEP 2017-153 - Rev 00
Substance No.: 2631

2022
05 Jan
Chemical Valid

Product

Rosuvastatin calcium

Substance

MOREPEN LABORATORIES LIMITED New Delhi IN

Certificate No.

R1-CEP 2015-309 - Rev 00

Substance No.

2631

Issue Date

2022-01-05

End Date

-

Country

India

Identifiers

Certificate No.: R1-CEP 2015-309 - Rev 00
Substance No.: 2631

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    14 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
Status Breakdown
14 total
  • Valid
Official Source

All data is sourced from the official EDQM CEP database (Certification of Suitability to the European Pharmacopoeia).

Visit EDQM
Record Details Preview

Click "View Details" on any record above to expand full details inline.

Country

India

Identifiers

Certificate No.: CEP 2025-532 - Rev 00
Substance No.: 2888

100% Official Data

Directly from the EDQM CEP database

Regular Updates

Data updated regularly from official sources

Trusted by Professionals

100K+ pharma professionals worldwide

Secure & Reliable

Enterprise-grade security and data protection

CEP data is obtained from the official EDQM (European Directorate for the Quality of Medicines) database.

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.